Appili Therapeutics Inc ( APLIF) - Key Metrics
APLIF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $0 | -$0.01 | $0 | $0 |
| 2026Q4 | $0 | -$0.01 | $0 | $0 |
| 2026Q3 | $0 | -$0.01 | $0 | $0 |
| 2026Q2 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q1 | $0 | -$0.01 | $0 | $0 |
APLIF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -0.31 |
| 2026Q4 | 0% | -0.48 |
| 2026Q3 | 0% | -0.69 |
| 2026Q2 | 0% | -0.59 |
| 2026Q1 | 0% | -0.46 |
APLIF
Price: $0.01
52 week price:
Earnings Per Share: -0.02 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 529464